Pipeline

Strong R&D, select partnerships, significant investment.

Our R&D strategy for a thriving product pipeline

As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class treatments in oncology, rare disease, and neuroscience – areas in which we have proven experience, global capabilities, and a strong network of partners.

Key facts

Building a high-value, sustainable pipeline

Filters

Disease Areas

Phase

Download pipeline chart

Group By

Oncology

Rare disease

Neuroscience

Phase – l

Phase – ll

Phase – lll

Registration

Oncology

IPN60210

R/R multiple myeloma and R/R DLBCL

TAZVERIK® (various combinations)

R/R malignancies

TAZVERIK® (+ hormonotherapy)

mCRPC

CABOMETYX® + ATEZOLIZUMAB

2L mCRPC

TAZVERIK + R2

2L FL

ONIVYDE®+ 5-FU/LV + OXALIPLATIN

1L PDAC

Rare disease

IPN60260

Viral cholestatic disease

FIDRISERTIB

FOP

ELAFIBRANOR

PSC

IPN60250

PSC

ELAFIBRANOR

2L PBC

BYLVAY®

Biliary atresia

PALOVAROTENE

FOP

BYLVAY®

Alagille syndrome

Neuroscience

IPN10200

Longer-acting neurotoxin Ax

IPN10200

Longer-acting neurotoxin Tx

Information shown as at the end of June 2023

R/Rrelapsed/refractory
DLBCLdiffuse large B-cell lymphoma
mCRPCmetastatic castration-resistant prostate cancer
FOPfibrodysplasia ossificans progressiva
PSCprimary sclerosing cholangitis
Axaesthetics
Txtherapeutics
2Lsecond line
1Lfirst line
R2lenalidomide + rituximab
FLfollicular lymphoma
PBCprimary biliary cholangitis
PDACpancreatic ductal adenocarcinoma
CLINICAL TRIALS

Help develop Ipsen products by participating in clinical trials: clinical trials in all phases require volunteers to test the efficacy and safety of new drugs. They offer an opportunity to contribute to advancing medicine and improving health outcomes for patients worldwide.

INVESTORS
INVESTORS

Ipsen provides comprehensive investor information, including our financial updates, reports and events calendar, plus shareholder news and regulated information in our dedicated investor pages.

OUR PARTNERSHIPS
OUR PARTNERSHIPS

At Ipsen, we believe that partnerships create possibilities. We seek to build partnerships that boost our capacity to improve or extend the lives of people living with cancer, rare diseases and neurological conditions.